IDEXX Laboratories stock holds steady as pet diagnostics stays central

IDEXX Laboratories (ISIN US45168D1046) remains a key name in veterinary diagnostics, reference laboratory services, and pet healthcare software for clinics and animal hospitals.

Business model

The company serves veterinarians with instruments, consumables, and testing platforms that support routine care, disease detection, and practice management. That mix gives the business recurring revenue characteristics that matter to investors tracking healthcare and animal-health exposure.

Market context

IDEXX Laboratories is listed on Nasdaq and trades in U.S. dollars, which keeps it inside the U.S. market framework that many retail investors follow closely. In structural terms, the stock is often assessed alongside other healthcare and diagnostics businesses rather than broad consumer names.

Veterinary diagnostics

Its product set centers on diagnostic instruments, tests, and software used in day-to-day veterinary practice. That product mix ties the company directly to recurring clinic workflows, which is a structural strength for a diagnostics platform.

Stock context

IDEXX Laboratories stock trades on Nasdaq as a U.S.-listed healthcare company. As of July 12, 2026, 12:16 a.m. UTC, the share price was not included here.